ALNY three-lens brief
Evidence-based stock research on ALNY. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.07% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -4.07% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 17.5pp over 30 days.
- Analyst mean target $371.35 — 50% above current (26 analysts).
- Debt-to-equity of 221% — balance-sheet-heavy.
ALNY closed at $247.51 (-4.07%) as of 2026-09-11. Market cap: $33.12B. P/E (trailing) 45.1. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $371.35 — 50% above current (26 analysts).. Concerns: moved -4.07% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $1.29B, net income $164.49M, free cash flow $271.54M.
Why three lenses on ALNY, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALNYacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ALNY" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALNY brief"></iframe>